Waters Launches Charge Detection Mass Spectrometry Technology
Waters Corporation has unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS), enabling accurate analysis of protein complexes, nucleic acids, and gene delivery vehicles.
The technology allows for distinguishing between empty, partial, full, and overfull viral vector capsids in less than 10 minutes per sample, addressing the challenges of analyzing large and heterogeneous drug modalities.
Delivering unmatched measurement and characterization for the broadest range of mega-mass biomolecules central to next-generation therapeutics and structural biology.
The launch of this technology aims to accelerate the development of next-generation biotherapeutics, including cell and gene therapies, mRNA, and complex protein therapeutics.
Author's summary: Waters introduces CDMS technology for biotherapeutics development.
More News
- Scottish corporate insolvencies up 41% in September
- The John Bolton Indictment Is Different
- Edinburgh Zoo welcomes pair of camel brothers
- 'It’s time to close the British steel industry'
- St Albert The Great College Students Give Heartwarming Welcome To Classmate Adam Returning After Three Years Away Due to Illness
- Government launches first digital ID today
- Steelers WR DK Metcalf Offers Blunt Assessment of Controversial Interception
- Captain KL to lead Cook Islands
- Overshoot: Exploring the implications of meeting 1.5°C climate goal ‘from above’
- The Ghost of Yotei map is a great tool, but choosing to not use it expands the world.